» Articles » PMID: 19198568

Chemical Modification of Viruses and Virus-like Particles

Overview
Date 2009 Feb 10
PMID 19198568
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Protein capsids derived from viruses may be modified by methods, generated, isolated, and purified on large scales with relative ease. In recent years, methods for their chemical derivatization have been employed to broaden the properties and functions accessible to investigators desiring monodisperse, atomic-resolution structures on the nanometer scale. Here we review the reactions and methods used in these endeavors, including the modification of lysine, cysteine, and tyrosine side chains, as well as the installation of unnatural amino acids, with particular attention to the special challenges imposed by the polyvalency and size of virus-based scaffolds.

Citing Articles

Engineering and Bio/Nanotechnological Applications of Virus Particles.

Mateu M, Valbuena A Subcell Biochem. 2024; 105:823-878.

PMID: 39738964 DOI: 10.1007/978-3-031-65187-8_22.


Virus nanotechnology for intratumoural immunotherapy.

Omole A, Zhao Z, Chang-Liao S, de Oliveira J, Boone C, Sutorus L Nat Rev Bioeng. 2024; 2(11):916-929.

PMID: 39698315 PMC: 11655125. DOI: 10.1038/s44222-024-00231-z.


Exploring the Landscape of the PP7 Virus-like Particle for Peptide Display.

Keshavarz-Joud P, Zhao L, Bobe D, Hernandez C, Kopylov M, Yen L ACS Nano. 2023; 17(18):18470-18480.

PMID: 37669408 PMC: 10540251. DOI: 10.1021/acsnano.3c06178.


A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future.

Holz E, Darwish M, Tesar D, Shatz-Binder W Pharmaceutics. 2023; 15(2).

PMID: 36839922 PMC: 9959917. DOI: 10.3390/pharmaceutics15020600.


Virus-like Particles: Fundamentals and Biomedical Applications.

Mejia-Mendez J, Vazquez-Duhalt R, Hernandez L, Sanchez-Arreola E, Bach H Int J Mol Sci. 2022; 23(15).

PMID: 35955711 PMC: 9369363. DOI: 10.3390/ijms23158579.